Mackenzie Financial Corp Increases Stock Position in Encompass Health Co. (NYSE:EHC)

Mackenzie Financial Corp raised its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 111.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 77,347 shares of the company's stock after purchasing an additional 40,739 shares during the quarter. Mackenzie Financial Corp owned 0.08% of Encompass Health worth $5,161,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of EHC. Lazard Asset Management LLC boosted its stake in shares of Encompass Health by 14.3% during the 4th quarter. Lazard Asset Management LLC now owns 1,290 shares of the company's stock worth $77,000 after buying an additional 161 shares during the last quarter. Bank of Montreal Can raised its holdings in Encompass Health by 1.5% in the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company's stock valued at $806,000 after acquiring an additional 173 shares during the period. Creative Planning grew its position in shares of Encompass Health by 3.5% during the 2nd quarter. Creative Planning now owns 6,074 shares of the company's stock worth $340,000 after purchasing an additional 204 shares in the last quarter. First Horizon Advisors Inc. grew its position in shares of Encompass Health by 18.8% during the 1st quarter. First Horizon Advisors Inc. now owns 1,415 shares of the company's stock worth $77,000 after purchasing an additional 224 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its position in shares of Encompass Health by 0.5% during the 3rd quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company's stock worth $3,246,000 after purchasing an additional 231 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the company a "buy" rating in a research report on Friday, February 9th. Barclays boosted their price target on shares of Encompass Health from $95.00 to $101.00 and gave the stock an "overweight" rating in a report on Thursday, March 28th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Royal Bank of Canada reissued an "outperform" rating and issued a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Finally, Stephens reissued an "overweight" rating and issued a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health has a consensus rating of "Buy" and an average price target of $83.22.

Encompass Health Trading Up 0.8 %

Shares of NYSE EHC traded up $0.60 during mid-day trading on Friday, reaching $79.22. The company had a trading volume of 784,352 shares, compared to its average volume of 710,077. The business's 50-day moving average is $77.38 and its 200-day moving average is $70.36. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market cap of $7.93 billion, a price-to-earnings ratio of 22.83, a price-to-earnings-growth ratio of 1.47 and a beta of 0.94. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $83.73.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The company had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.24 billion. Equities analysts expect that Encompass Health Co. will post 3.96 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health's payout ratio is 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.